Pissarnitski DA, Zhao Z, Cole D, Wu WL, Domalski M, Clader JW, Scapin G, Voigt J, Soriano A, Kelly T, Powles MA, Yao Z, Burnett DA (2016)
Scaffold-hopping from xanthines to tricyclic guanines: A case study of dipeptidyl peptidase 4 (DPP4) inhibitors
Bioorganic & Medicinal Chemistry 24: 5534

Clader JW, Billard W, Binch H, 3rd, Chen LY, Crosby G, Jr., Duffy RA, Ford J, Kozlowski JA, Lachowicz JE, Li S, Liu C, McCombie SW, Vice S, Zhou G, Greenlee WJ (2004)
Muscarinic M2 antagonists: anthranilamide derivatives with exceptional selectivity and in vivo activity
Bioorganic & Medicinal Chemistry 12: 319

Palani A, Dugar S, Clader JW, Greenlee WJ, Ruperto V, Duffy RA, Lachowicz JE (2004)
Isopropyl amide derivatives of potent and selective muscarinic M2 receptor antagonists
Bioorganic & Medicinal Chemistry Lett 14: 1791

Boyle CD, Chackalamannil S, Clader JW, Greenlee WJ, Josien HB, Kaminski JJ, Kozlowski JA, McCombie SW, Nazareno DV, Tagat JR, Wang Y, Zhou G, Billard W, Binch H, Crosby G, Cohen-Williams M, Coffin VL, Cox KA, Grotz DE, Duffy RA, Ruperto V, Lachowicz JE (2001)
Metabolic stabilization of benzylidene ketal M(2) muscarinic receptor antagonists via halonaphthoic acid substitution
Bioorganic & Medicinal Chemistry Lett 11: 2311

Wang Y, Chackalamannil S, Hu Z, Clader JW, Greenlee W, Billard W, Binch H, Crosby G, Ruperto V, Duffy RA, McQuade R, Lachowicz JE (2000)
Design and synthesis of piperidinyl piperidine analogues as potent and selective M2 muscarinic receptor antagonists
Bioorganic & Medicinal Chemistry Lett 10: 2247